Literature DB >> 27914930

Biological fitness and natural selection of amantadine resistant variants of avian influenza H5N1 viruses.

E M Abdelwhab1, Jutta Veits2, Thomas C Mettenleiter2.   

Abstract

Outbreaks caused by the highly pathogenic H5N1 avian influenza virus (A/H5N1) devastated the poultry industry in several countries and posed a significant pandemic threat. In addition to culling of infected poultry and vaccination, amantadine has been applied in poultry in some countries to control the spread of the virus. The prevalence of the amantadine resistance marker at position 31 (Ser31Asn) of the M2 protein increased over time. However, little is known about the biological fitness and selection of H5N1 amantadine resistant strains over their sensitive counterparts. Here, using reverse genetics we investigated the biological impact of Ser31Asn in M2 commonly seen in viruses in clade 2.2.1.1 in farmed poultry in Egypt. Findings of the current study indicated that the resistance to amantadine conferred by Asn31 evolved rapidly after the application of amantadine in commercial poultry. Both the resistant and sensitive strains replicated at similar levels in avian cell culture. Asn31 increased virus entry into the cells and cell-to-cell spread and was genetically stable for several passages in cell culture. Moreover, upon co-infection of cell culture resistant strains dominated sensitive viruses even in the absence of selection by amantadine. Together, rapid emergence, stability and domination of amantadine-resistant variants over sensitive strains limit the efficacy of amantadine in poultry.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amantadine resistance; Antivirals; Avian influenza virus H5N1; Chickens; Clade 2.2.1.1; Ser31Asn

Mesh:

Substances:

Year:  2016        PMID: 27914930     DOI: 10.1016/j.virusres.2016.11.032

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  3 in total

Review 1.  Zoonotic Potential of Influenza A Viruses: A Comprehensive Overview.

Authors:  Ahmed Mostafa; Elsayed M Abdelwhab; Thomas C Mettenleiter; Stephan Pleschka
Journal:  Viruses       Date:  2018-09-13       Impact factor: 5.048

Review 2.  Zoonotic Influenza and Human Health-Part 2: Clinical Features, Diagnosis, Treatment, and Prevention Strategies.

Authors:  K Mehta; L W Goneau; J Wong; A G L'Huillier; J B Gubbay
Journal:  Curr Infect Dis Rep       Date:  2018-08-01       Impact factor: 3.725

3.  In Vitro and In Vivo Antiviral Studies of New Heteroannulated 1,2,3-Triazole Glycosides Targeting the Neuraminidase of Influenza A Viruses.

Authors:  Omnia Kutkat; Ahmed Kandeil; Yassmin Moatasim; Yaseen A M M Elshaier; Wael A El-Sayed; Samir T Gaballah; Ahmed El Taweel; Mina Nabil Kamel; Mohamed El Sayes; Mohammed A Ramadan; Rabeh El-Shesheny; Farouk M E Abdel-Megeid; Richard Webby; Ghazi Kayali; Mohamed A Ali
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.